GENMAB AS SP.ADR/1/10DK 1 (GE91) — Financial Flexibility Index
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of €314.00 Million (operating CF €301.00 Million minus capex €13.00 Million) represents 0% of total liabilities (€7.03 Billion). Also explore GENMAB AS SP.ADR/1/10DK 1 equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GENMAB AS SP.ADR/1/10DK 1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. Check GENMAB AS SP.ADR/1/10DK 1 strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Year-by-year free cash flow to debt coverage for GENMAB AS SP.ADR/1/10DK 1. For the full company profile including market capitalisation, see GENMAB AS SP.ADR/1/10DK 1 market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | €1.24 Billion | €1.19 Billion | €7.03 Billion | ▼ -80.1% |
| 2024 | 0.89x | €1.13 Billion | €1.08 Billion | €1.27 Billion | ▼ -58.0% |
| 2023 | 2.11x | €1.15 Billion | €1.10 Billion | €546.23 Million | ▲ +41.4% |
| 2022 | 1.49x | €608.67 Million | €563.05 Million | €408.32 Million | ▲ +46.1% |
| 2021 | 1.02x | €377.55 Million | €339.18 Million | €370.09 Million | — |